| Followers | 19 |
| Posts | 6559 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Monday, August 05, 2019 8:12:25 AM
Thank you Rich from CVSY. Wolf
We wish to extend a warm thank you to all of our contributors.
Hemp derived CBD vs Marijuana derived CBD
https://discovercbd.com/pages/hemp-derived-cbd-vs-marijuana-derived-cbd
Conclusion
At this point, multiple states are already selling medical marijuana or are looking to jump on board; however, there are still other states that may never be open to the idea of medical marijuana. Either way, hemp-derived CBD is legal and obtainable in all 50 states making it much more accessible than THC.
Because every individual responds differently to CBD and THC, it is up to the consumer to decide what is best for themselves. Hopefully, the information presented here and on the rest of the website will help you make a more informed decision on the CBD products you purchase.
We wish to extend a warm thank you to all of our contributors.
Hemp derived CBD vs Marijuana derived CBD
https://discovercbd.com/pages/hemp-derived-cbd-vs-marijuana-derived-cbd
Conclusion
At this point, multiple states are already selling medical marijuana or are looking to jump on board; however, there are still other states that may never be open to the idea of medical marijuana. Either way, hemp-derived CBD is legal and obtainable in all 50 states making it much more accessible than THC.
Because every individual responds differently to CBD and THC, it is up to the consumer to decide what is best for themselves. Hopefully, the information presented here and on the rest of the website will help you make a more informed decision on the CBD products you purchase.
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
